Tobacco Use Disorder
- PMID: 34823737
- PMCID: PMC8630801
- DOI: 10.1016/j.mcna.2021.08.011
Tobacco Use Disorder
Abstract
Tobacco use disorder is highly prevalent; more than a billion individuals use tobacco worldwide. Popular views on the addictive potential of tobacco often underestimate the complex neural adaptations that underpin continued use. Although sometimes trivialized as a minor substance, effects of nicotine on behavior lead to profound morbidity over a lifetime of exposure. Innovations in processing have led to potent forms of tobacco and delivery devices. Proactive treatment strategies focus on pharmacotherapeutic interventions. Innovations on the horizon hold promise to help clinicians address this problem in a phenotypically tailored manner. Efforts are needed to prevent tobacco use for future generations.
Keywords: Nicotine; Pharmacotherapeutic interventions; Smoking treatment; Tobacco use.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Ms. Evers-Casey: None declared.
References
-
- Lewis RS, Nicholson JS. Aspects of the evolution of Nicotiana tabacum L. and the status of the United States Nicotiana Germplasm Collection. Genet Resour Crop Evol. 2007. June 1;54(4):727–40.
-
- Ćwintal M, Sawicka B, Otekunrin O, Skiba D. Plant-derived stimulants and psychoactive substances -social and economic aspects. J Med - Clin Res Rev. 2020. November 1;5:313–35.
-
- Kishore K Monograph of Tobacco (Nicotiana tabacum). Indian J Drugs. 2014;2(1):5–23.
-
- Lalruatfela B A review on tobacco and its effect on health. Sci Vis. 2019. March 31;19(1):16–23.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources